Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• Drug-eluting stents (DES) are used to treat in-stent restenosis (ISR) after bare metal stent placement.
• The safety of overlapping DES, particularly regarding vessel wall toxicity, requires further investigation.

Purpose of the Study:

• To evaluate the 1-year intravascular ultrasound (IVUS) findings in patients with ISR treated with overlapping sirolimus-eluting stents (SES).
• To assess potential toxic effects on the vessel wall associated with overlapping SES implantation.

Main Methods:

• A prospective study involving eight patients with ISR requiring two overlapping SES (18 mm length each) for complete lesion coverage.
• Implantation of SES with a >1-mm overlap.
• 1-year follow-up using intravascular ultrasound (IVUS) to analyze quantitative measurements within the overlapped segment.

Main Results:

• No significant quantitative changes were observed in IVUS measurements within the overlapped stent segment at the 1-year follow-up.
• This suggests that overlapping SES implantation did not induce significant adverse remodeling or toxicity in the vessel wall over one year.

Conclusions:

• Overlapping sirolimus-eluting stents for the treatment of in-stent restenosis appear to be safe concerning vessel wall effects at 1-year follow-up.
• Intravascular ultrasound findings support the absence of significant adverse changes in the overlapped segment, indicating a favorable safety profile for this technique.